• Media type: E-Article
  • Title: Deficiency of a sulfotransferase for sialic acid-modified glycans mitigates Alzheimer’s pathology
  • Contributor: Zhang, Zui; Takeda-Uchimura, Yoshiko; Foyez, Tahmina; Ohtake-Niimi, Shiori; Narentuya; Akatsu, Hiroyasu; Nishitsuji, Kazuchika; Michikawa, Makoto; Wyss-Coray, Tony; Kadomatsu, Kenji; Uchimura, Kenji
  • imprint: Proceedings of the National Academy of Sciences, 2017
  • Published in: Proceedings of the National Academy of Sciences
  • Language: English
  • DOI: 10.1073/pnas.1615036114
  • ISSN: 0027-8424; 1091-6490
  • Origination:
  • Footnote:
  • Description: <jats:title>Significance</jats:title> <jats:p>Keratan sulfate (KS) is an extracellular sulfated glycan covalently attached to core proteins in the brain. Here, we show that a type of KS with a certain molecular mass in microglia and its synthetic enzyme GlcNAc6ST1, previously known as a sulfotransferase for ligands of L-selectin, are upregulated in model mice and patients with Alzheimer’s disease. GlcNAc6ST1 deficiency resulted in increased amyloid-β phagocytosis and hyperresponsiveness to an antiinflammatory cytokine in primary microglia. Moreover, amyloid-β pathology was mitigated in GlcNAc6ST1-deficient Alzheimer’s model mice. These data support a model in which GlcNAc6ST1 regulates microglial functions via synthesizing sialic acid-modified KS, a potential ligand for microglial carbohydrate-recognizing receptors, in Alzheimer’s pathology.</jats:p>
  • Access State: Open Access